Skip to main content

Renal resistive index and nocturnal non-dipping: Is there an association in essential hypertension?

Abstract

Renal Doppler ultrasonography (RDU) is a useful method to determine renal resistive index (RRI). The RRI has been used to evaluate target organ damage (TOD) in essential hypertension. Nocturnal non-dipping of blood pressure (BP) in essential hypertension was also associated with TOD. The relationship between increased RRI and non-dipping has not been specifically studied before. Patients with newly diagnosed essential hypertension underwent 24-h ambulatory BP monitoring, biochemistry analysis, 24-h urine testing, and RDU. Totally, 198 patients (137 women, 61 men, aged 53.8 ± 11.4 years) were included. Sixty-two patients were non-dippers, and 56 patients had increased RRI. RRI was increased in 32.3% of non-dipper patients and in 26.5% of dipper patients (P = 0.402). The RRIs of dippers were lower than the RRIs of non-dippers (0.65 ± 0.06 vs. 0.68 ± 0.07, P = 0.036). Multivariate logistic regression analysis of potential factors predicting increased RRI disclosed that advanced age (OR 1.090, CI 1.042–1.140, P < 0.0001) and increased pulse pressure (OR 1.037, CI 1.012–1.062, P = 0.004) were independently associated with increased RRI. In multivariate linear regression analysis, using the same independent variables, we found that square root-transformed RRI was independently associated with age (Beta + 0.366, P < 0.0001) and pulse pressure (Beta + 0.222, P = 0.001). Increased RRI and nocturnal non-dipping are not independently associated with each other in newly diagnosed essential hypertensive patients. Possible different mechanisms, or the same mechanisms but with different activation levels, may be responsible for the increased RRI and non-dipping as discrete pathologies.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Ohta Y, Fujii K, Arima H et al (2005) Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography. J Hypertens 23:1905–1911. doi:10.1097/01.hjh.0000181323.44162.01

    PubMed  Article  CAS  Google Scholar 

  2. Platt JF, Ellis JH, Rubin JM et al (1990) Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease: correlation of resistive index with biopsy findings. AJR Am J Roentgenol 154:1223–1227

    PubMed  CAS  Google Scholar 

  3. Knapp R, Plotzeneder A, Frauscher F et al (1995) Variability of Doppler parameters in the healthy kidney: an anatomic-physiologic correlation. J Ultrasound Med 14:427–429

    PubMed  CAS  Google Scholar 

  4. Okura T, Watanabe S, Miyoshi K et al (2004) Intrarenal and carotid hemodynamics in patients with essential hypertension. Am J Hypertens 17:240–244. doi:10.1016/j.amjhyper.2003.10.005

    PubMed  Article  Google Scholar 

  5. Pickering TG, Kario K (2001) Nocturnal non-dipping: what does it augur? Curr Opin Nephrol Hypertens 10:611–616. doi:10.1097/00041552-200109000-00010

    PubMed  Article  CAS  Google Scholar 

  6. Verdecchia P, Schillaci G, Porcellati C (1991) Dippers versus non-dippers. J Hypertens 9(Suppl):S42–S44

    Article  CAS  Google Scholar 

  7. Pickering TG, Devereux RB (1987) Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk. Am Heart J 114:925–928. doi:10.1016/0002-8703(87)90589-8

    PubMed  Article  CAS  Google Scholar 

  8. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470

    PubMed  CAS  Google Scholar 

  9. Levey AS, Eckardt KU, Tsukamoto Y et al (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67:2089–2100. doi:10.1111/j.1523-1755.2005.00365.x

    PubMed  Article  Google Scholar 

  10. O’Brien E, Pickering T, Asmar R et al (2002) Working group on blood pressure monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 7:3–17. doi:10.1097/00126097-200202000-00002

    PubMed  Article  Google Scholar 

  11. Jones SC, Bilous M, Winship S et al (2004) Validation of the OSCAR 2 oscillometric 24-h ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices. Blood Press Monit 9:219–223. doi:10.1097/00126097-200408000-00007

    PubMed  Article  Google Scholar 

  12. Veglio F, Provera E, Pinna G et al (1992) Renal resistive index after captopril test by echo-Doppler in essential hypertension. Am J Hypertens 5:431–436

    PubMed  CAS  Google Scholar 

  13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997). Diabetes Care 20:1183–1197

    Google Scholar 

  14. Shimizu Y, Itoh T, Hougaku H et al (2001) Clinical usefulness of duplex ultrasonography for the assessment of renal arteriosclerosis in essential hypertensive patients. Hypertens Res 24:13–17. doi:10.1291/hypres.24.13

    PubMed  Article  CAS  Google Scholar 

  15. Petersen LJ, Petersen JR, Ladefoged SD et al (1995) The pulsatility index and the resistive index in renal arteries in patients with hypertension and chronic renal failure. Nephrol Dial Transplant 10:2060–2064

    PubMed  CAS  Google Scholar 

  16. Jensen G, Bardelli M, Volkmann R et al (1994) Renovascular resistance in primary hypertension: experimental variations detected by means of Doppler ultrasound. J Hypertens 12:959–964. doi:10.1097/00004872-199408000-00015

    PubMed  Article  CAS  Google Scholar 

  17. Pontremoli R, Viazzi F, Martinoli C et al (1999) Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. Nephrol Dial Transplant 14:360–365. doi:10.1093/ndt/14.2.360

    PubMed  Article  CAS  Google Scholar 

  18. Mostbeck GH, Kain R, Mallek R et al (1991) Duplex Doppler sonography in renal parenchymal disease. Histopathologic correlation. J Ultrasound Med 10:189–194

    PubMed  CAS  Google Scholar 

  19. Fava C, Minuz P, Patrignani P et al (2006) Renal artery stenosis and accelerated atherosclerosis: which comes first? J Hypertens 24:1687–1696. doi:10.1097/01.hjh.0000242388.92225.2c

    PubMed  Article  CAS  Google Scholar 

  20. Franklin SS, Khan SA, Wong ND et al (1999) Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 100:354–360

    PubMed  CAS  Google Scholar 

  21. Benetos A, Zureik M, Morcet J et al (2000) A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 35:673–680. doi:10.1016/S0735-1097(99)00586-0

    PubMed  Article  CAS  Google Scholar 

  22. Simons PC, Algra A, Bots ML et al (1999) Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART study (second manifestations of arterial disease). Circulation 100:951–957

    PubMed  CAS  Google Scholar 

  23. Blacher J, Pannier B, Guerin AP et al (1998) Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570–574

    PubMed  CAS  Google Scholar 

  24. Domanski MJ, Davis BR, Pfeffer MA et al (1999) Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension 34:375–380

    PubMed  CAS  Google Scholar 

  25. Verdecchia P, Schillaci G, Guerrieri M et al (1990) Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528–536

    PubMed  CAS  Google Scholar 

  26. Zakopoulos N, Stamatelopoulos S, Toumanidis S et al (1997) 24 h blood pressure profile affects the left ventricle independently of the pressure level. A study in untreated essential hypertension diagnosed by office blood pressure readings. Am J Hypertens 10:168–174. doi:10.1016/S0895-7061(96)00326-3

    PubMed  Article  CAS  Google Scholar 

  27. Giaconi S, Levanti C, Fommei E et al (1989) Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 2:259–261

    PubMed  CAS  Google Scholar 

  28. Timio M, Venanzi S, Lolli S et al (1995) ‘Non-dipper’ hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 43:382–387

    PubMed  CAS  Google Scholar 

  29. Ohkubo T, Imai Y, Tsuji I et al (1997) Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 10:1201–1207. doi:10.1016/S0895-7061(97)00274-4

    PubMed  Article  CAS  Google Scholar 

  30. Kohara K, Nishida W, Maguchi M et al (1995) Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension 26:808–814

    PubMed  CAS  Google Scholar 

  31. Ebata H, Hojo Y, Ikeda U et al (1995) Differential effects of an alpha 1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens Res 18:125–130. doi:10.1291/hypres.18.125

    PubMed  Article  CAS  Google Scholar 

  32. Zacharieva S, Kirilov G, Kalinov K et al (2002) Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women. Gynecol Endocrinol 16:461–467. doi:10.1080/713603160

    PubMed  Article  CAS  Google Scholar 

  33. Sharifi AM, Akbarloo N, Heshmatian B et al (2003) Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension. Pharmacol Res 47:201–209. doi:10.1016/S1043-6618(02)00319-5

    PubMed  Article  CAS  Google Scholar 

  34. Laursen JB, Rajagopalan S, Galis Z et al (1997) Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95:588–593

    PubMed  CAS  Google Scholar 

  35. Watanabe S, Okura T, Kurata M et al (2006) Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension. Clin Exp Hypertens 28:451–461. doi:10.1080/10641960600798671

    PubMed  Article  CAS  Google Scholar 

  36. Richards AM, Nicholls MG, Espiner EA et al (1984) Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet 1:757–761. doi:10.1016/S0140-6736(84)91276-5

    PubMed  Article  CAS  Google Scholar 

  37. Omboni S, Parati G, Palatini P et al (1998) Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on ambulatory monitoring of pressure and lisinopril evaluation. J Hypertens 16:733–738. doi:10.1097/00004872-199816060-00003

    CAS  Google Scholar 

Download references

Acknowledgment

We gratefully acknowledge the collaboration of Prof. Dr. Fatih Boyvat from the Department of Radiology.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Baris Afsar.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Afsar, B., Ozdemir, N.F., Elsurer, R. et al. Renal resistive index and nocturnal non-dipping: Is there an association in essential hypertension?. Int Urol Nephrol 41, 383–391 (2009). https://doi.org/10.1007/s11255-008-9455-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-008-9455-3

Keywords

  • Doppler ultrasonography
  • Essential hypertension
  • Nocturnal non-dipping
  • Renal resistive index